4.0
2023-05-23
- New edition completely updated after 8 months of work with many new co-authors and collaborators.
- Technical fixes and improvements.
3.12.1
2023-02-20
Fixes and improvements
3.11.1
2022-03-24
Fixes and improvements
3.10.1
2021-09-08
Minor bug fixes and improvements
3.8
2020-10-08
- COVID-19 section updates (treatment)
- Modification to acetaminophen poisoning section
- Minor edits to all chapters
- More than 100 new references
3.7
2020-07-01
- New diagnostic algorithm for pulmonary embolism.
- New drugs in the Drugs section: upadacitinib (Rinvoq)
- Minor edits to all chapters.
- More than 100 new references.
3.6
2020-03-29
- New section on COVID-19.
- Minor updates to the Infectious Diseases chapter.
3.5
2020-02-01
- 43 new diagnostic algorithms.
- Updated Pneumonia page with the new ATS/IDSA 2019 guidelines for community acquired pneumonia.
- New systemic lupus erythematosus diagnostic criteria (EULAR/ACR 2019)
- Added rosomozumab as a treatment option for osteoporosis.
- Minor edits to all chapters.
- More than 100 new references.
3.4
2019-10-18
- Major gastroenterology and oncology chapter updates.
- Update of the Heparin-Induced Thrombocytopenia section according to the 2018 recommendations of the American Society of Hematology.
- Update on NAC Treatment for Acetaminophen Poisoning.
- Addition of Constans criteria for Deep-Vein Thrombosis of the Upper Extremities.
- Addition of a section on Mycoplasma genitalium.
- Minor edits to all chapters.
3.3.1
2019-08-29
Minor fixes
3.3
2019-08-12
- New sections: neuroendocrine tumors in the endocrinology chapter and smoking cessation in the respirology chapter.
- New subsection: steroid weaning in “Adrenal Disorders”.
- Minor changes to all chapters.
- New drugs in the Drugs section: risankisumab (Skyrizi).
- Additions of more than 120 new references.
3.2.3
2019-07-12
More bug fixes
3.2.2
2019-07-04
Small bug fixes
3.2.1
2019-03-13
Fixed typos and minor content update
3.2
2019-03-01
- Major app update. Use your subscription on the new web platform!
- 2018 Focused Update of the Canadian Cardiovascular Society for the Management of Atrial Fibrillation.
- New: Canadian Syncope Risk Score
- Pyoderma gangrenosum: new diagnostic criteria
- Digitalis intoxication: correction
- Framingham Score: correction
- Minor edits to all chapters
- New drugs in the pharmacology section: Baricitinib (Olumiant), dapagliflozin + saxagliptin (Qtern), empagliflozin + linagliptin (Glyxambi), ertugliflozin (Steglatro), ertugliflozin + metformin (Segluromet), ertugliflozin + sitagliptin (Steglujan), Soliqua, vedolizumab (Entyvio), Xultophy
- More than 100 new references
3.1.1
2018-11-29
Bug fix related to the new iPad Pro
3.1
2018-10-03
- Update to the Stroke section with POINT trial.
- Update to the Dizziness section.
- Update to the Sepsis section.
- Update to the MGUS subsection.
- Revised Superficial Thrombophlebitis section.
- Minor update to the cardiology, GI, hematology, ID, general internal medicine, nephrology and oncology chapters.
- ECG examples.
- Links to educational videos in the cardiology and neurology chapters.
- New drug in the pharmacology section: Trelegy Ellipta
- More than 100 new references.
3.0.4
2018-06-09
Bug fix and minor content update.
3.0.3
2018-05-14
Bug fix and minor content update
3.0.2
2018-05-09
Bug fix and minor content update
3.0.1
2018-05-01
Version 3.0 of the application!
Based on the newest edition of the book, which is now in its seventh edition.
Content completely revised and updated.
6 new pages - Hypogonadism - Varicella - shingles - Medical disorders related to alcohol - Falls - Oncological emergencies - Eosinophilic pulmonary diseases
10 new sections - Pancreatic cysts - Functional dyspepsia - Gastroparesis - Gastritis - Eosinophilic esophagitis - Microscopic colitis - Vertebral osteomyelitis - Preoperative evaluation: liver diseases - Preoperative evaluation: neurological diseases - Preoperative evaluation: rheumatological diseases
New elements in the Appendix section - Induction agents - Drug interactions with P-glycoprotein - AUDIT Questionnaire - CIWA-Ar Scale
More than 100 new references.
Subscription system: the application is now offered as an annual subscription. This system allows you to perform content updates indefinitely without having to purchase a new full version periodically.
Improved note system, allowing you to export your notes to save them elsewhere. You can now add notes without linking to a particular page.
Integrated timer, to enable practicing physicians to record CME hours.
Complete overhaul of the foundations of the application, to better adapt to new devices.
3.0
2018-04-30
Version 3.0 of the application!
Based on the newest edition of the book, which is now in its seventh edition.
Content completely revised and updated.
6 new pages
- Hypogonadism
- Varicella - shingles
- Medical disorders related to alcohol
- Falls
- Oncological emergencies
- Eosinophilic pulmonary diseases
10 new sections
- Pancreatic cysts
- Functional dyspepsia
- Gastroparesis
- Gastritis
- Eosinophilic esophagitis
- Microscopic colitis
- Vertebral osteomyelitis
- Preoperative evaluation: liver diseases
- Preoperative evaluation: neurological diseases
- Preoperative evaluation: rheumatological diseases
New elements in the Appendix section
- Induction agents
- Drug interactions with P-glycoprotein
- AUDIT Questionnaire
- CIWA-Ar Scale
More than 100 new references.
Subscription system: the application is now offered as an annual subscription. This system allows you to perform content updates indefinitely without having to purchase a new full version periodically.
Improved note system, allowing you to export your notes to save them elsewhere. You can now add notes without linking to a particular page.
Integrated timer, to enable practicing physicians to record CME hours.
Complete overhaul of the foundations of the application, to better adapt to new devices.
2.9
2017-12-15
- Target drug dosage added to the CHF section
- New drugs in the Appendix section
- More than 70 new references
2.8
2017-09-22
- Hypertension: 2017 Canadian Hypertension Education Program (CHEP) update
- 2017 H. pylori ACG recommendations
- New section on HIV prevention
- 2017 ACC/AHA valvular heart disease update
- Updated epilepsy section with new 2014 and 2017 ILAE definitions
- New medications in appendix section: Invokamet (canagliflozin/metformin), Lancora (ivabradine), Synjardy (empagliflozin/metformin)
- More than 100 new references
2.7.1
2017-04-05
- Bug fix
- Minor content update
2.7
2017-03-21
- 2017 Canadian Cardiovascular Society Guidelines for preoperative assessment.
- Completely updated infectious diseases chapter.
Updated lung cancer section, including the new 2017 TNM staging.
- Updated hyponatremia section.
- New diagnosis criteria for neurocognitive disorders (DSM-5).
- Added liraglutide (Saxenda) for the treatment of obesity.
- New medication in the appendix section: edoxaban (Lixiana), sarilumab (Kevzara).
- More than 100 new references.
2.6
2016-12-22
Revised Hematology and Respirology chapters
New Zika section
Updates
- 2016 Canadian dyslipidemia consensus guidelines
- 2016 American HIV consensus guidelines
- 2015 American infectious endocarditis consensus guidelines
- 2016 Canadian atrial fibrillation guidelines
- 2016 IDSA-ATS nosocomial pneumonia consensus guidelines
- 2016 Toronto H pylori treatment consensus guidelines
New MedCalX links: HEART, PERC, SOFA, qSOFA
New medication in appendix section: ixekizumab, sécukinumab, vorapaxar (Zontivity)
2.5
2016-07-13
- New recommendations for lung and colon cancer screening
- New sepsis definition (Sepsis-3 2016 Consensus)
- New IOM 2015 criteria for chronic fatigue/myalgic encephalomyelitis syndrome
- New irritable bowel syndrome criteria (Rome IV)
- 2016 CCS update on heart failure treatment
- 2016 AT10 update for anticoagulation in thromboembolic disease
- 2016 update on type 2 diabetes treatment
- 2016 update to the Canadian Hypertension Education Program
- New medication: brivaracetam (Brivlera), exenatide (Bydureon), alirocumab (Praluent), evolocumab (Repatha), perindopril/amlodipine (Viacoram), dapagliflozin/metformin (Xigduo)
- Around a hundred new references
- Bug fixes
2.4
2016-03-02
- New Lyme Disease page
- New STI page
- Refreshed and updated GI, ID, and Neuro chapters
- More than 100 new references
- New medications: albiglutide, dulaglutide, empagliflozine, new bronchodilators (Arnuity Ellipta, Duaklir, Incruse, Inspiolto), sacubitril/valsartan
- Fixed a MedCalx integration bug
2.3.1
2015-11-21
- Fixed a bug that prevented the new references from being shown.
- Fixed typos
2.3
2015-11-10
- Revised and refreshed Nephrology chapter.
- Added the European Society of Cardiology Consensus to the references.
- More than 75 new references.
2.2
2015-07-19
- Updated endocrinology, hematology, infectious diseases and respirology chapters.
- New “Chikungunya" topic.
- Update to “Cardiac Preoperative Evaluation of a Noncardiac Surgery” according to the 2014 ACC-AHA consensus.
- Update to the preoperative evaluation sections regarding newer anticoagulants.
- Update to “Arterial Hypertension” with the CHEP 2015 recommendations.
- Edits to “Melanoma”.
- New references.
2.1
2015-03-13
- Updated references
- Update to HIV treatment based on the International Antiviral Society Panel 2014
- Bug fix
2.0
2015-01-14
– Major update: new look, better search, and many more neat little details. Explore!
– Complete Respirology chapter revision
– Update to the “Valvular Heart Disease” page based on the ACC-AHA 2014 consensus
– Update to the “Arterial Hypertension and Pregnancy” page
– Update to “anticoagulation in atrial fibrillation” according to the 2014 Canadian Atrial Fibrillation Guidelines
– New page on Bronchiectasis
– Added alogliptin and canagliflozin as antihyperglycemics agents
– More than 70 new and updated references.
1.5
2014-06-11
- New “Fungal Infections” page
- Added a few pathogens to the community acquired pneumonia section
- Update to the Canadian Hypertension Education Program Recommendations (2014)
- Updates to the dyslipidemia treatment objective guidelines
- Updated vasculitis section in line with the Chapel Hill 2012 classification
- New medication: aclidinium (COPD), perampanel (epilepsy)
- Updated steroid equivalence table
- More than 25 new references
1.4
2014-04-01
- Fine tuning to the note synchronization system
- Minor edits
1.3
2014-01-23
• CCS guidelines for management of Afib
• Updated gout guidelines
• Added the 5 subtypes of MI
• 70 new references